- Home
- AXSM vs RNR Comparison
AXSM vs RNR Comparison
Compare AXSM & RNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AXSM | RNR |
|---|---|---|
| Founded | 2012 | 1993 |
| Country | United States | Bermuda |
| Employees | N/A | 1040 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 12.8B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | AXSM | RNR |
|---|---|---|
| Price | $236.50 | $288.49 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 17 | 14 |
| Target Price | $211.12 | ★ $322.31 |
| AVG Volume (30 Days) | ★ 562.3K | 343.0K |
| Earning Date | 05-04-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.53% |
| EPS Growth | ★ 38.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $57.24 | N/A |
| Revenue Next Year | $55.88 | $3.19 |
| P/E Ratio | ★ N/A | $5.42 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $96.09 | $231.17 |
| 52 Week High | $238.56 | $318.20 |
Technical Indicators
Market Signals| Indicator | AXSM | RNR |
|---|---|---|
| Relative Strength Index (RSI) | 65.39 | 47.30 |
| Support Level | $148.87 | $288.22 |
| Resistance Level | N/A | $306.03 |
| Average True Range (ATR) | 7.82 | 7.12 |
| MACD | -1.51 | -0.80 |
| Stochastic Oscillator | 84.85 | 44.74 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About RNR RenaissanceRe Holdings Ltd.
RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.